CSF3 and systemic lupus erythematosus: Previously, lupus‐prone MRL‐lpr mice treated with a low dose of G‐CSF exhibited exacerbated kidney disease with enhanced glomerular deposition of Ig, whereas those on high dose treatment were protected, possibly by local downmodulation of Fc receptor expression in the glomeruli.33